Critical illness-related corticosteroid insufficiency in cardiogenic shock

Br J Anaesth. 2013 Sep;111(3):512-3. doi: 10.1093/bja/aet271.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adrenal Insufficiency / complications*
  • Adrenal Insufficiency / drug therapy*
  • Adrenergic alpha-Agonists / therapeutic use
  • Adult
  • Anti-Inflammatory Agents / therapeutic use*
  • Antihypertensive Agents / therapeutic use
  • Aspirin / therapeutic use
  • Bisoprolol / therapeutic use
  • Critical Illness
  • Epinephrine / therapeutic use
  • Fibrinolytic Agents / therapeutic use
  • Hirudins
  • Humans
  • Hydrocortisone / therapeutic use*
  • Male
  • Peptide Fragments / therapeutic use
  • Piperazines / therapeutic use
  • Prasugrel Hydrochloride
  • Ramipril / therapeutic use
  • Recombinant Proteins / therapeutic use
  • Shock, Cardiogenic / drug therapy*
  • Shock, Cardiogenic / etiology*
  • Thiophenes / therapeutic use
  • Treatment Outcome

Substances

  • Adrenergic alpha-Agonists
  • Anti-Inflammatory Agents
  • Antihypertensive Agents
  • Fibrinolytic Agents
  • Hirudins
  • Peptide Fragments
  • Piperazines
  • Recombinant Proteins
  • Thiophenes
  • Prasugrel Hydrochloride
  • Ramipril
  • Aspirin
  • bivalirudin
  • Hydrocortisone
  • Bisoprolol
  • Epinephrine